OMUFA - Screening Non-Sterile OTC Monograph Products for Microbial Contamination

Forecast Overview

NAICS

541714

Performance end

11/2025

OMUFA - A study will be designed to evaluate non-sterile, aqueous based, OTC monographdrugs for microbial contamination. This will enhance FDA's surveillance of OTC monograph products andpotentially reduce the incidence of adverse events.

Source

Source

HHS SBCX Forecast Export

Source file

Forecast.csv

Official source

Agency forecast source

Last verified

2026-08-31

Agency-published contact: · TBD@fda.hhs.gov

Related Federal Entities

• Department of Health and Human Services · agency
• OCP/DARS IDIQ 5 year purchase of cells · related forecast
• OCP/DARS new clinical studies IDIQ 5 year contract with M ceiling · related forecast
• PK IDIQ- Post-market Bioequivalence of Generic Drug Products · related forecast
• Analysis of Chemical Structures and Therapeutic Activity of Agents for HIV, TB, and HBV (ChemDB) · related forecast
• Evaluation and Testing Services for Vaccines and Other Biologics for Infectious Diseases · related forecast
• Federal Technology Spending Map · spending map
• Federal Opportunity Research · resource